補足体と血解性抗体:メルカプトエタノールによって誘発された活動の変化
Science (New York, N.Y.)
|February 12, 1965
まとめ
メルカプトエタノールは,血解性抗体を保護する細胞結合補充成分を破壊しません. しかし,自由補足成分Cは,
科学分野:
- 免疫学 免疫学とは
- バイオケミストリー バイオケミストリー
背景:
- 補足成分は免疫反応に不可欠ですが,その安定性と化学薬品との相互作用は完全に理解されていません.
- 細胞結合血解性抗体の活動は,関連する補完タンパク質の完全性によって影響を受けることがあります.
研究 の 目的:
- メルカプトエタノールの細胞結合および自由補完成分に対する効果を調査する.
- 個々の補完成分 (C'1,C'1a,C'2,C'3,C'4) のメルカプトエタノールに対する感受性を決定する.
- 抗体破壊に対する細胞結合補完成分の保護的役割を探求する.
主な方法:
- メルカプトエタノールによる細胞結合および自由補完成分の処理.
- 補完成分破壊と血解性抗体の完全性の評価.
- メルカプトエタノール処理後のC1活動の評価.
主要な成果:
- メルカプトエタノールは,細胞に結合した補完成分を破壊しませんでした.
- 細胞結合補充成分は,細胞結合血解性抗体の破壊を防止しました.
- 溶液中では,C'3とC'4はメルカプトエタノールに対して感受性があり,C'1,C'1a,C'2は耐性であった.
- メルカプトエタノールの0.01M濃度は,C1a活性化とは関係なく,C1活動を増強した.
- メルカプトエタノールとヨドアセタミドを併用した治療は,特定の補足成分を破壊するために必要でした.
結論:
- 細胞結合補充成分は,メルカプトエタノールに対する耐性を示し,抗体の安定性に寄与する.
- 個々の補充成分は,メルカプトエタノールに対する異なる感受性を示し,補充経路の研究に意味があります.
- メルカプトエタノールはC1の活性を調節することができ,補充の調節における役割を示唆しています.
キーワード:
アンチボディは,抗体です.センターリフューゲーション褒め言葉 褒め言葉ダイエリーシス (Dialysis) とは実験実験室での研究ギニアブタはギニアブタです.ヘモロシシス ヘモロシスとはメルカプトエタノール (MERCAPTOETHANOL) とは薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とはウサギ (うさぎ) はウサギである.羊 羊は羊を飼っている.スルフヒドリル化合物さらに関連する動画
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
関連する概念動画
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...